CheckMate: a patient-side clinical-trial explainer
Paste the URL of any clinical-trial listing or published paper and CheckMate explains it in plain English, flags what the trial did not measure, and translates statistics into real-world odds a patient can act on.
Patients and caregivers evaluating clinical trials or recent treatment research
- Trial-listing decoder that explains eligibility, endpoints, and phases without jargon
- Plain-English translations of hazard ratios, p-values, and confidence intervals
- 'What this study didn't measure' flag (e.g., no long-term data, no head-to-head comparison)
- Bring-to-doctor summary sheet with the three questions worth asking on the visit
Frontier open models enable reliable, citation-grounded explanations of dense medical literature—patients increasingly arrive to appointments with AI-generated questions.
Patients actively search health info online (77% start at search engines) and ClinicalTrials.gov is the default registry, but a PMC study finds the registry doesn't align with patient preferences — indicating unmet need rather than proven demand for a paid explainer tool.Patient preferences when searching for clinical trials and adherence of ClinicalTrials.gov ↗77% of Online Health Researchers Start at Search Engines ↗
Several direct competitors already target this niche — MedTranslate (patient-facing, free), clinical-plain-lang on GitHub, TranslatorMind and XlatorHub clinical-trial translators — and many general calculators already convert stats to ARR/NNT, leaving the combined 'explain + flag gaps + translate odds' niche narrow rather than wide-open.MedTranslate - Offline AI Clinical Trial Translator ↗Clinical Trial Translator - XlatorHub ↗
The closest patient-facing competitor (MedTranslate) is explicitly 'free for patients,' and patients are notoriously reluctant to pay for health information tools — no surfaced examples of a paid subscription trial-explainer app with traction, while abundant free alternatives exist.MedTranslate - Offline AI Clinical Trial Translator ↗
Clinical-trial output is a permanent, growing stream (400k+ studies on ClinicalTrials.gov) and frontier models improving citation grounding is a durable tailwind, but regulatory risk around medical AI advice and patient liability are persistent headwinds.Home | ClinicalTrials.gov ↗
Core build (URL/paper ingestion + plain-English summary + stats translation via RAG over frontier models) is straightforward, but medical accuracy and hallucination risk require a serious QA/review pipeline plus FDA-adjacent disclaimers, raising real engineering and legal cost.Building blocks: The ultimate guide to AI in clinical trials ↗